Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 4/20 | 0.39 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.39 |
| ▸ | NOS3 | P29474 | 3/20 | 0.37 |
| ▸ | NOS1 | P29475 | 3/20 | 0.37 |
| ▸ | NOS2 | P35228 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7522556 | 0.75 | HSP90AA1 (0.32) | — | |
| SCHEMBL1864672 | 0.75 | HRH3 (0.39) | HRH3NOS2ALDH1A1TSHRKDM4E | |
| SCHEMBL5718810 | 0.74 | ALDH1A1 (0.45) | HRH3HRH4NOS3NOS1NOS2 | |
| SCHEMBL306173 | 0.73 | TDP1 (0.39) | HRH3ALDH1A1KDM4ESMN1; SMN2SLC6A4 | |
| SCHEMBL29066337 | 0.72 | ALDH1A1 (0.43) | HRH3HRH4NOS3NOS1NOS2 | |
| SCHEMBL28254738 | 0.71 | KCNH2 (0.42) | ALDH1A1TSHRKDM4ESMN1; SMN2SLC6A4 | |
| SCHEMBL27794520 | 0.71 | KCNH2 (0.42) | ALDH1A1TSHRKDM4ESMN1; SMN2SLC6A4 | |
| SCHEMBL20499801 | 0.71 | KCNH2 (0.42) | ALDH1A1TSHRKDM4ESMN1; SMN2SLC6A4 | |
| SCHEMBL20747030 | 0.71 | KCNH2 (0.42) | ALDH1A1TSHRKDM4ESMN1; SMN2SLC6A4 | |
| SCHEMBL2708603 | 0.71 | KCNH2 (0.42) | ALDH1A1TSHRKDM4ESMN1; SMN2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107743502-A | Solidification composition filling | 爱客多有限公司 | 2018-02-27 | — | — | CN | claimed |
| US-20170306096-A1 | MOISTURE CURABLE COMPOSITIONS | MOMENTIVE PERFORMANCE MATERIALS INC. | 2017-10-26 | — | — | US | claimed |
| EP-3221374-A1 | MOISTURE CURABLE COMPOSITIONS | Momentive Performance Materials Inc. (US) | 2017-09-27 | — | — | EP | claimed |
| WO-2016185209-A1 | CURING COMPOSITIONS | AQDOT LIMITED (GB) | 2016-11-24 | — | — | WO | claimed |
| WO-2016081790-A1 | MOISTURE CURABLE COMPOSITIONS | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2016-05-26 | — | — | WO | claimed |
| EP-2106415-B1 | TERTIARY AMINES BLOCKED WITH POLYMER ACIDS | HUNTSMAN PETROCHEMICAL LLC (US) | 2016-04-20 | — | — | EP | claimed |
| US-20150094387-A1 | Use of Thickening Agents as Polyurethane Amine Catalyst Diluents | HUNTSMAN PETROCHEMICAL LLC (US) | 2015-04-02 | — | — | US | claimed |
| EP-2742078-A1 | USE OF THICKENING AGENTS AS POLYURETHANE AMINE CATALYST DILUENTS | Huntsman Petrochemical LLC (US) | 2014-06-18 | — | — | EP | claimed |
| CN-103732645-A | Use of thickeners as polyurethane amine catalyst diluents | HUNTSMAN PETROCHEMICAL LLC | 2014-04-16 | — | — | CN | claimed |
| WO-2013023125-A1 | USE OF THICKENING AGENTS AS POLYURETHANE AMINE CATALYST DILUENTS | HUNTSMAN PETROCHEMICAL LLC (US) | 2013-02-14 | — | — | WO | claimed |
| US-20100099785-A1 | TERTIARY AMINES BLOCKED WITH POLYMER ACIDS | HUNTSMAN PETROCHEMICAL CORPORATION (US) | 2010-04-22 | — | — | US | claimed |
| CN-101631811-A | Polymer-terminated tertiary amines | HUNTSMAN SPEC CHEM CORP | 2010-01-20 | — | — | CN | claimed |
| EP-2106415-A1 | TERTIARY AMINES BLOCKED WITH POLYMER ACIDS | Huntsman Petrochemical Corporation (US) | 2009-10-07 | — | — | EP | claimed |
| WO-2008089411-A1 | TERTIARY AMINES BLOCKED WITH POLYMER ACIDS | HUNTSMAN PETROCHEMICAL CORPORATION (US) | 2008-07-24 | — | — | WO | claimed |
| US-5294647-A | Polyurethane insulation | ATLAS ROOFING CORPORATION (US) | 1994-03-15 | — | — | US | claimed |
| EP-3768759-A1 | EXTENDED POT-LIFE FOR LOW TEMPERATURE CURING POLYURETDIONE RESINS | Covestro LLC (US) | 2021-01-27 | — | — | EP | disclosed |
| US-10633477-B2 | Extended pot-life for low temperature curing polyuretdione resins | COVESTRO LLC (US) | 2020-04-28 | — | — | US | disclosed |
| US-5449700-A | Polyetherurethane copolymers which may contain amines or polyamines | MILES INC. (US) | 1995-09-12 | — | — | US | disclosed |
| US-4425446-A | INSULATING FOAM | SEALED AIR CORPORATION (US) | 1984-01-10 | — | — | US | disclosed |
| US-4401769-A | SOFTENERS, POLYISOCYANURATES, POLYCARBODIMIDES | SEALED AIR CORPORATION (US) | 1983-08-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170306096-A1 | MOISTURE CURABLE COMPOSITIONS | DOT1L, EHMT2, CDH1 | HRH3 99/4885HRH4 292/4885NOS3 219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.